Hinge Health (NYSE:HNGE) President James Pursley Sells 16,000 Shares

Hinge Health Inc. (NYSE:HNGE) President James Pursley sold 16,000 shares of Hinge Health stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $53.79, for a total transaction of $860,640.00. Following the sale, the president directly owned 780,223 shares in the company, valued at $41,968,195.17. The trade was a 2.01% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

James Pursley also recently made the following trade(s):

• On Monday, March 23rd, James Pursley sold 15,000 shares of Hinge Health stock. The shares were sold at an average price of $42.26, for a total transaction of $633,900.00.

Hinge Health Stock Up 1.0%

Shares of HNGE traded up $0.51 during trading hours on Wednesday, reaching $53.49. 990,814 shares of the company traded hands, compared to its average volume of 1,735,060. The company’s fifty day moving average price is $45.61 and its two-hundred day moving average price is $44.52. The company has a market capitalization of $4.14 billion and a price-to-earnings ratio of -4.33. Hinge Health Inc. has a 12 month low of $30.08 and a 12 month high of $62.18.

Hinge Health (NYSE:HNGE) last announced its earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.12 by $0.33. The firm had revenue of $182.31 million for the quarter. Hinge Health had a negative net margin of 78.95% and a negative return on equity of 310.62%. The company’s revenue for the quarter was up 47.2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.30 EPS. On average, analysts expect that Hinge Health Inc. will post 1.21 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. KeyCorp set a $55.00 target price on shares of Hinge Health in a research note on Wednesday, February 11th. Barclays lifted their price target on shares of Hinge Health from $52.00 to $62.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Zacks Research raised shares of Hinge Health from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 13th. Citigroup reissued an “outperform” rating on shares of Hinge Health in a research report on Wednesday, May 6th. Finally, Piper Sandler reissued an “overweight” rating and set a $95.00 price target on shares of Hinge Health in a research report on Wednesday, May 6th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $67.40.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the business. Janney Montgomery Scott LLC lifted its position in Hinge Health by 3.3% during the 1st quarter. Janney Montgomery Scott LLC now owns 9,400 shares of the company’s stock valued at $362,000 after acquiring an additional 300 shares during the period. Wells Fargo & Company MN lifted its position in Hinge Health by 160.0% during the 4th quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock valued at $25,000 after acquiring an additional 336 shares during the period. Lazard Asset Management LLC lifted its position in Hinge Health by 0.6% during the 1st quarter. Lazard Asset Management LLC now owns 63,705 shares of the company’s stock valued at $2,456,000 after acquiring an additional 386 shares during the period. First Horizon Corp raised its holdings in Hinge Health by 163.9% in the fourth quarter. First Horizon Corp now owns 855 shares of the company’s stock worth $40,000 after buying an additional 531 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd purchased a new position in Hinge Health in the fourth quarter worth about $26,000.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.